Active substance
Trandolapril
- US FDA 11
- Health Canada 25
- US price lines 3
- NHS prices 4
- Safety 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TRANDOLAPRIL | 1MG; 2MG; 4MG | tablet · oral | LUPIN | Prescription | 12 Jun 2007 |
| TRANDOLAPRIL | 1MG; 2MG; 4MG | tablet · oral | AUROBINDO PHARMA | Prescription | 12 Jun 2007 |
| TRANDOLAPRIL | 2MG; 4MG; 1MG | tablet · oral | EPIC PHARMA | Prescription | 18 Jun 2008 |
| MAVIK | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | ABBVIE | Discontinued | 26 Apr 1996 |
| TRANDOLAPRIL | 1MG; 2MG; 4MG | tablet · oral | TEVA PHARMS | Discontinued | 12 Dec 2006 |
| TRANDOLAPRIL | 1MG; 2MG; 4MG | tablet · oral | EPIC PHARMA LLC | Discontinued | 12 Jun 2007 |
| TRANDOLAPRIL | 2MG; 1MG; 4MG | tablet · oral | CHARTWELL MOLECULAR | Discontinued | 12 Jun 2007 |
| TRANDOLAPRIL | 1MG; 2MG; 4MG | tablet · oral | WATSON LABS | Discontinued | 12 Jun 2007 |
| TRANDOLAPRIL | 1MG; 2MG; 4MG | tablet · oral | INVAGEN PHARMS | Discontinued | 12 Jun 2007 |
| TRANDOLAPRIL | 1MG; 2MG; 4MG | tablet · oral | PHARMOBEDIENT | Discontinued | 28 Apr 2008 |
| TRANDOLAPRIL | 1MG; 2MG; 4MG | tablet · oral | PHARMAZONE | Discontinued | 25 Aug 2008 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| AURO-TRANDOLAPRIL | 02471868 | 0.5 MG | CAPSULE · ORAL | AURO PHARMA INC |
| AURO-TRANDOLAPRIL | 02471876 | 1 MG | CAPSULE · ORAL | AURO PHARMA INC |
| AURO-TRANDOLAPRIL | 02471884 | 2 MG | CAPSULE · ORAL | AURO PHARMA INC |
| AURO-TRANDOLAPRIL | 02471892 | 4 MG | CAPSULE · ORAL | AURO PHARMA INC |
| MAVIK | 02231457 | 0.5 MG | CAPSULE · ORAL | BGP PHARMA ULC |
| MAVIK | 02231459 | 1 MG | CAPSULE · ORAL | BGP PHARMA ULC |
| MAVIK | 02231460 | 2 MG | CAPSULE · ORAL | BGP PHARMA ULC |
| MAVIK | 02239267 | 4 MG | CAPSULE · ORAL | BGP PHARMA ULC |
| PMS-TRANDOLAPRIL | 02357755 | 0.5 MG | CAPSULE · ORAL | PHARMASCIENCE INC |
| PMS-TRANDOLAPRIL | 02357763 | 1 MG | CAPSULE · ORAL | PHARMASCIENCE INC |
| PMS-TRANDOLAPRIL | 02357771 | 2 MG | CAPSULE · ORAL | PHARMASCIENCE INC |
| PMS-TRANDOLAPRIL | 02357798 | 4 MG | CAPSULE · ORAL | PHARMASCIENCE INC |
| SANDOZ TRANDOLAPRIL | 02325721 | 0.5 MG | CAPSULE · ORAL | SANDOZ CANADA INCORPORATED |
| SANDOZ TRANDOLAPRIL | 02325748 | 1 MG | CAPSULE · ORAL | SANDOZ CANADA INCORPORATED |
| SANDOZ TRANDOLAPRIL | 02325756 | 2 MG | CAPSULE · ORAL | SANDOZ CANADA INCORPORATED |
| SANDOZ TRANDOLAPRIL | 02325764 | 4 MG | CAPSULE · ORAL | SANDOZ CANADA INCORPORATED |
| TRANDOLAPRIL | 02488698 | 1 MG | CAPSULE · ORAL | PRO DOC LIMITEE |
| TRANDOLAPRIL | 02488701 | 2 MG | CAPSULE · ORAL | PRO DOC LIMITEE |
| TRANDOLAPRIL | 02488728 | 4 MG | CAPSULE · ORAL | PRO DOC LIMITEE |
| TRANDOLAPRIL | 02525046 | 1 MG | CAPSULE · ORAL | SANIS HEALTH INC |
| TRANDOLAPRIL | 02525054 | 2 MG | CAPSULE · ORAL | SANIS HEALTH INC |
| TRANDOLAPRIL | 02525070 | 4 MG | CAPSULE · ORAL | SANIS HEALTH INC |
| TRANDOLAPRIL | 02526565 | 1 MG | CAPSULE · ORAL | SIVEM PHARMACEUTICALS ULC |
| TRANDOLAPRIL | 02526573 | 2 MG | CAPSULE · ORAL | SIVEM PHARMACEUTICALS ULC |
| TRANDOLAPRIL | 02526581 | 4 MG | CAPSULE · ORAL | SIVEM PHARMACEUTICALS ULC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | TRANDOLAPRIL 1 MG TABLET | $0.15716 | per EA | 23 Sep 2026 |
| US NADAC | TRANDOLAPRIL 2 MG TABLET | $0.16218 | per EA | 23 Sep 2026 |
| US NADAC | TRANDOLAPRIL 4 MG TABLET | $0.15608 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Trandolapril 1mg capsules | £17.16 | 28 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Trandolapril 2mg capsules | £2.94 | 28 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Trandolapril 4mg capsules | £12.64 | 28 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Trandolapril 500microgram capsules | £1.67 | 14 capsule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 20 Aug 2019 TARKA — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Drug Interactions - US FDA 2 Aug 2017 MAVIK — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Drug Interactions
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.